MedTrace Logo

Telephone-based Motivational Interviewing for Smoking Cessation in Crohn's Disease Patients

NCT04225403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2020-01-14

No results posted yet for this study

Summary

Quitting smoking unequivocally improves the course of Crohn's disease (EC), and therefore, it should be one of the main therapeutic targets in the treatment of this disease. The goal of the study was to know the effectiveness of motivational intervention 5 R for smoking cessation in patients with Crohn's disease performed by telephone by nursing, in relation to those who did not receive such intervention.

For this purpose, a controlled, randomized, parallel and open clinical trial was designed. The subjects were patients with Crohn's disease that were actively smoking EC. They were all \>18 years old and they had internet access and e-mail. Those who were already in a process of smoking cessation were excluded from the study. Experimental intervention consisted of a motivational intervention for smoking cessation through telephone every 3 months for one year.

Conditions

  • Crohn Disease

Interventions

BEHAVIORAL

Telephone-based motivational interviewing for smoking cessation

The motivational brief intervention is known by the acronym 5 R and lasts about 5-10 minutes. It is an approach based on the principles of motivational interviewing and develops the intervention in five short steps: * Relevance. Help patients identify why personal reasons may be relevant to quitting smoking. * Risks. Help identify what negative consequences tobacco use has. * Rewards. Help identify potential benefits of quitting smoking. * Resistors. Help patients identify barriers to smoking cessation, which can often include fear of withdrawal symptoms, failure, wainweight, face social situations, etc. * Repeat. Repeat the intervention at 3 months if you do not advance at the stage of change.

Sponsors & Collaborators

  • GETTEII ( Grupo Enfermero de Trabajo en Enfermedad Inflamatoria Intestinal

    collaborator UNKNOWN

  • Department of Health, Generalitat de Catalunya

    collaborator OTHER_GOV

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Ester Navarro Correal, MsC · Hospital Universitari Vall d'Hebron Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-06
Primary Completion
2017-05-08
Completion
2017-05-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04225403 on ClinicalTrials.gov